Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.
Jabs
D A
DA
Rosenbaum
J T
JT
D001528:Behcet Syndrome / Q000188:drug therapy*; D005104:Expert Testimony; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins
D007166:Immunosuppressive Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins